Medingo’s new president and CEO to set up US operations
This article was originally published in Clinica
Executive Summary
Medingo (Yoqneam, Israel), a company that is about to launch its first product – an innovative insulin dispenser in the form of a skin patch plus remote control to direct levels of insulin delivered – has made Pete Wehrly president and CEO. He will also lead the setting up of operations in the US, replacing Ofer Yodfat in that role. Dr Yodfat will continue as general manager of Medingo Israel. Mr Wehrly is a veteran Medtronic executive with more than 20 years’ experience in the industry. Before joining the company, he was senior vice-president and president of Medtronic’s spinal and biologics division. The company has also appointed Kim Stebbings as vice-president of marketing. Ms Stebbings joins from Florida-based Anodyne Therapy (infrared light therapy) where she was vice-president of sales and marketing. She has more than 20 years’ experience as a medical technology sales and marketing executive.